14 Recruiting Trials

Clinical Trials
for Kidney Disease in Washington

14 clinical trials for Kidney Disease are currently recruiting participants at study sites in Washington. Study-related care is provided at no cost.

14
Recruiting trials
9
Study sites
2
Cities
8
Industry-sponsored
4
Phase 2
7
Phase 3

Kidney Disease clinical trials in Washington: what to expect

Kidney disease trials are mostly for chronic kidney disease that is slowly getting worse, including kidney disease caused by diabetes. They test medicines meant to slow the decline in kidney function and protect the heart, usually on top of the standard blood pressure and diabetes treatments. Specific kidney diseases such as IgA nephropathy, FSGS and polycystic kidney disease now have many trials of their own, and separate studies enroll people on dialysis or living with a transplant.

In Washington, recruiting kidney disease studies are concentrated in Seattle and Spokane. 8 of the 14 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who kidney disease trials usually look for

Trials describe kidney disease by two numbers: the filtration rate (eGFR) from a blood test and the amount of protein in the urine. Most enroll an eGFR between about 20 and 75 and a urine protein level above a cut-off, both measured at screening. Nearly all ask that you have taken a stable dose of a blood-pressure medicine of the ACE inhibitor or ARB type for three months, and many allow or require an SGLT2 inhibitor. IgA nephropathy and FSGS trials need a past kidney biopsy. Common exclusions are a transplant, dialysis and uncontrolled blood pressure.

What taking part involves

Screening includes blood and urine tests, sometimes a 24-hour urine collection, and a review of your records. Trials then run one to three years with visits every four to twelve weeks for labs and blood pressure, taking a study pill or injection added to your usual medicines; placebo arms are common and an extension often follows. Your nephrologist keeps managing your care. Study medicine and tests are free and visits are usually paid.

Questions worth asking the study team

Which stage the trial enrolls and whether you fit it; whether any of your medicines change; how often labs are needed; the chance of placebo; and whether you will be told your own kidney results during the study.

Showing 14 of 14 recruiting Kidney Disease trials in Washington

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
PHASE2 Seattle, Washington +3 sites NCT05822609
This trial is looking for adults with type 1 diabetes and kidney disease to see how a medication called semaglutide affects their condition. Participants will need to complete some tests and take the study medication for 26 weeks.
Recruiting
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
PHASE3 Phoenix, Arizona +4 sites NCT05457283
This trial is looking for children and young adults aged 1 to 18 who have chronic kidney disease and proteinuria. Participants will take a treatment called finerenone alongside their current heart medicine for about 18 months.
Recruiting
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
PHASE3 Birmingham, Alabama +4 sites NCT07107945
This trial is looking for children aged 2 to 17 who have chronic kidney disease. Participants will take a daily tablet for 6 months followed by 1 year of another medication, with regular check-ups to monitor their health.
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
PHASE3 Huntsville, Alabama +4 sites NCT07753993
This trial is looking for adults with chronic kidney disease to see how well elecoglipron works compared to a placebo. Participants must be on certain medications for their condition before joining the study.
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
PHASE2 San Dimas, California +4 sites NCT06717698
This trial is looking for adults with chronic kidney disease, with or without type 2 diabetes, who are living with overweight or obesity. Participants will receive either a new medicine, a standard medicine, or a placebo for up to 43 weeks.
Recruiting
Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
NA Seattle, Washington +4 sites NCT06613568
This trial is looking for adults with end stage kidney disease who have stable kidney function and can learn how to use a new hemodialysis system. Participants will either use the system under professional care or at home with a trained care partner.
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
PHASE3 Fairhope, Alabama +4 sites NCT06742723
This trial is looking for adults with chronic kidney disease and high blood pressure. If you join, you will take medications to see how they affect your kidney health and heart-related risks.
Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
PHASE2 Alabaster, Alabama +4 sites NCT05312879
This trial is looking for adults and children with a specific type of kidney disease caused by genetics. Participants will receive the drug VX-147 to assess its effectiveness and safety.
Recruiting
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PHASE2 Birmingham, Alabama +4 sites NCT06902558
This trial is looking for adults with a specific type of kidney disease. Participants will receive either the study drug or a placebo every 4 weeks for 92 weeks and will attend regular check-ups.
Recruiting
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
PHASE3 Long Beach, California +4 sites NCT05931276
This trial is looking for patients on hemodialysis who take certain beta blockers. Participants will receive either metoprolol or carvedilol to see how these medications affect heart health.
Recruiting
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
PHASE3 Stanford, California +4 sites NCT06217302
This trial is looking for adults with type 1 diabetes and diabetic kidney disease. Participants will take either a study drug or a placebo for three years, while receiving education on managing their diabetes.
Recruiting
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
PHASE1 Seattle, Washington +1 sites NCT05065372
This trial is looking for young people with type 1 diabetes who use automated insulin delivery systems or multiple daily insulin injections. Participants will take metformin for four months to see how it affects their health.
Recruiting
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
N/A Seattle, Washington +1 sites NCT05008276
This trial is looking for teenagers with type 2 diabetes and obesity. Participants will help researchers learn how puberty affects kidney health in young people with diabetes.
Recruiting
Kidney Precision Medicine Project
N/A Tucson, Arizona +4 sites NCT04334707
This trial is looking for people with acute or chronic kidney disease. Participants will provide kidney tissue samples and undergo assessments to help find better treatments for these conditions.
Recruiting

Where the Kidney Disease studies are in Washington

  • University of Washington, Seattle4 trials
  • Seattle Children's Hospital, Seattle3 trials
  • Providence Sacred Heart Medical Center, Spokane2 trials
  • Research Site, Seattle2 trials
  • Providence Medical Research Center, Spokane1 trial
  • Seattle Children's Hospital - Nephrology, Seattle1 trial

Counts are recruiting studies listing at least one site in Washington, from ClinicalTrials.gov, refreshed every two days.

Kidney Disease clinical trials in Washington: common questions

How many Kidney Disease clinical trials are recruiting in Washington?
TrialFinder currently lists 14 recruiting Kidney Disease clinical trials with study sites in Washington. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Kidney Disease clinical trials located in Washington?
Study sites for the Kidney Disease trials listed on this page include Seattle. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Kidney Disease clinical trial in Washington?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Kidney Disease trials in Washington also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Kidney Disease clinical trial in Washington?
Each study sets its own criteria based on age, Kidney Disease diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
What stage of kidney disease do trials look for?
Trials state an eGFR range and a urine protein threshold rather than a stage name; most cover stages 2 to 4. People on dialysis or with a transplant have separate trials written for them.
Do I need a kidney biopsy to join?
Trials for IgA nephropathy, FSGS and lupus nephritis require a past biopsy confirming the diagnosis. Trials for diabetic or general chronic kidney disease do not.
Will I keep my current kidney and blood pressure medicines?
Yes. Kidney trials add the study treatment to a stable regimen, usually including an ACE inhibitor or ARB, and your own nephrologist continues to manage them.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Kidney Disease trials near you in Washington.

Get Matched — Free
No insurance required

Kidney disease trials evaluate SGLT2 inhibitors, dialysis protocols, renal transplant regimens, and supportive-care strategies for chronic and acute kidney disease.

All Kidney Disease trials →